Recent Updates On Nutraceutical Product Registration With CDSCO: What You Need To Know

India’s nutraceutical sector is undergoing a significant regulatory evolution as the Central Drugs Standard Control Organization expands its role in product oversight.

Traditionally governed by the Food Safety and Standards Authority of India, nutraceuticals are now facing increased scrutiny, especially those with:

• Higher active ingredient concentrations 
• Pharmaceutical-like dosage forms (capsules, tablets, injectables in some cases) 
• Therapeutic or disease-related claims 

With the market projected to reach $18 billion by 2025, these regulatory updates aim to ensure product safety, efficacy, and consumer protection.

What are the latest CDSCO updates for nutraceutical registration in India?
India is shifting regulatory oversight of certain nutraceuticals to CDSCO, introducing stricter requirements for product claims, GMP compliance, digital submissions, and enhanced safety monitoring to align with pharmaceutical standards.

Key Regulatory Updates (2024–2025)

1. Shift of Regulatory Oversight

A government-appointed expert panel has recommended that select nutraceutical categories be regulated under CDSCO instead of FSSAI.

Products Likely to Shift

• High-dose vitamins and minerals 
• Amino acids and protein derivatives 
• Probiotics and microbiome-based products 
• Botanical extracts with pharmacological effects 

This shift aims to:

• Remove regulatory ambiguity 
• Improve safety evaluation 
• Align high-risk products with drug-like regulatory standards

FSSAI vs CDSCO Oversight

2. Stricter Product Claims & Labeling Controls

Under the evolving framework:

• CDSCO will regulate: 
  • Disease risk reduction claims 
  • Therapeutic or preventive claims 
• FSSAI will continue to oversee: 
  • Nutritional claims 
  • General wellness claims 

New Expectations

• Scientific substantiation for all claims 
• Pre-approval of labels and promotional materials 
• Restrictions on misleading or exaggerated advertising 

Non-compliance may lead to product recalls or regulatory action.

3. GMP Requirements & Quality Standards

Nutraceutical manufacturers will increasingly be required to follow pharmaceutical-grade GMP standards.

Key Expectations

• Controlled manufacturing environments 
• Validated processes 
• Quality control testing 
• Batch traceability 

Aligns nutraceutical production with global best practices for safety and consistency.

GMP Impact on Nutraceuticals

4. Digital Registration & Documentation

Applications will increasingly be submitted through CDSCO’s digital systems, such as the SUGAM portal.

Dossier Requirements

• Complete ingredient composition 
• Safety and toxicological data 
• Claims substantiation 
• Manufacturing details 
• Labeling and artwork 

Digitalization ensures:

• Faster processing 
• Better traceability 
• Reduced manual errors 

5. Enhanced Post-Market Surveillance

CDSCO is expected to strengthen monitoring through:

• Adverse event reporting systems 
• Product quality inspections 
• Market surveillance programs 

Ensures ongoing safety beyond initial approval.

Compliance Checklist for Nutraceutical Companies

Regulatory Readiness Checklist

Common Challenges for Industry

Best Practices for Smooth Registration

• Conduct early regulatory classification 
• Develop science-backed claims strategy 
• Invest in GMP-compliant manufacturing 
• Maintain complete and audit-ready documentation 
• Monitor evolving CDSCO and FSSAI guidance 

Quick Facts

• CDSCO expanding role in nutraceutical regulation 
• High-risk products shifting from FSSAI to CDSCO 
• Stricter claim validation required 
• GMP compliance becoming mandatory 
• Digital submissions via SUGAM portal 

Why These Changes Matter

India’s regulatory shift reflects a move toward greater scientific rigor and global harmonization. With oversight from both Central Drugs Standard Control Organization and Food Safety and Standards Authority of India, companies must demonstrate expertise, transparency, and compliance excellence. Strong regulatory practices build consumer trust, product credibility, and long-term market success.

How Maven Regulatory Solutions Supports Nutraceutical Compliance

Our Services

• Regulatory classification (CDSCO vs FSSAI) 
• Dossier preparation and submission 
• Claims substantiation and review 
• GMP compliance support 
• Labeling and advertising compliance 
• Post-market surveillance strategy 

Why Choose Maven

• Deep expertise in Indian regulatory frameworks 
• Integrated food + pharma compliance knowledge 
• End-to-end regulatory support 
• Faster, compliant market entry 

Navigate India’s Nutraceutical Regulations with Confidence

Launching or expanding nutraceutical products in India?

Partner with Maven Regulatory Solutions for compliant, efficient, and future-ready registration strategies

•  Avoid regulatory delays
• Ensure claim and labeling compliance
• Strengthening product credibility

Conclusion

India’s evolving nutraceutical regulations mark a shift toward stricter oversight, improved safety, and global alignment.

As CDSCO takes on a larger role, companies must adapt to higher compliance expectations, stronger scientific validation, and more structured approval pathways.

With the right strategy and expert support, these changes present an opportunity to build trust, ensure safety, and thrive in a rapidly growing market.

FAQs

1. Who regulates nutraceuticals in India?
Primarily FSSAI, but CDSCO is expanding oversight for certain products.

2. Which products may fall under CDSCO?
High-dose vitamins, probiotics, botanicals, and drug-like formulations.

3. Are claims regulated?
Yes, CDSCO will regulate therapeutic claims, while FSSAI handles general health claims.

4. Is GMP required?
Increasingly yes, especially for higher-risk products.

5. How are applications submitted?
Through digital platforms like the SUGAM portal.

6. How can Maven help?
By providing end-to-end regulatory and compliance support.